Eversept Partners, LP Vericel Corp Transaction History

Eversept Partners, LP

  • $991 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$9.1 - $14.8 $681,016 - $1.11 Million
-74,837 Closed
0 $0
Q2 2018

Nov 08, 2023
BUY
$9.6 - $14.6 $718,435 - $1.09 Million
74,837 New
74,837 $725,000
Q2 2018

Aug 14, 2018
BUY
$9.6 - $14.6 $718,435 - $1.09 Million
74,837 New
74,837 $726,000

Others Institutions Holding VCEL

# of Institutions
293
Shares Held
50.7M
Call Options Held
98.2K
Put Options Held
135K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.3B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email